During a recent visit to ReiThera's facilities, I saw first-hand how the company is leveraging decades of vector expertise, manufacturing capabilities, and a focus on quality to help clients bring gene therapies and vaccines from concept to clinic.
During a recent visit to ReiThera's facilities in Italy, I saw first-hand how the company is leveraging decades of vector expertise, manufacturing capabilities, and a focus on quality to help clients bring gene therapies and vaccines from concept to clinic.
Shutterstock Zeljko Radojko
The week's biggest stories from this industry, direct to your inbox.
